Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma

This clinical trial aims to evaluate the feasibility and safety of early post-operative brain PET-MRI imaging in adult patients who have undergone surgery for suspected glioblastoma. The study also seeks to validate specific nuclear imaging parameters for better detection of residual tumor tissue compared to standard gadolinium-enhanced MRI. The main objectives are to determine whether early PET-MRI within 48 hours post-surgery is feasible, to assess potential side effects related to imaging procedures, and to explore if PET parameters such as SUVmax, metabolic volume, and tumor-to-striatum ratio can improve the detection of tumor residue. A total of 15 patients will be included at a single site in France. Participants will undergo PET-MRI using 18F-DOPA and gadolinium, and will be monitored for radiation exposure and possible adverse events up to 24 hours after imaging.

NCT Number	NCT07274397
Lead Sponsor	Beta Emitting Accurate Monitored Systems Collaborators: Assistance Publique - Hôpitaux de Paris
Conditions	Glioblastoma, Brain Tumors, Brain Imaging
Enrollment	15 participants
Start Date	2026-04-17
Primary Completion	2027-04-17 (estimated)
Study Completion	2027-04-17 (estimated)
Updated on ClinicalTrials.gov	2026-06-08